Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.
Open | $5.760 |
Close | - |
Volume / Avg. | 112.338K / 641.037K |
Day Range | 5.700 - 6.180 |
52 Wk Range | 4.775 - 42.600 |
Market Cap | $128.770M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 229.66% |
Days to Cover | 7.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agenus (NASDAQ: AGEN) through any online brokerage.
Other companies in Agenus’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX), FibroGen (NASDAQ:FGEN) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Agenus (NASDAQ: AGEN) was reported by B. Riley Securities on Monday, March 18, 2024. The analyst firm set a price target for 5.00 expecting AGEN to fall to within 12 months (a possible -18.67% downside). 10 analyst firms have reported ratings in the last year.
The stock price for Agenus (NASDAQ: AGEN) is $6.1477 last updated Today at April 23, 2024 at 10:05 AM EDT.
There are no upcoming dividends for Agenus.
Agenus’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Agenus.
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.